Last updated: February 20, 2026
What is the Scope of EP3603693?
European Patent EP3603693 claims a novel drug compound identified as [specific compound or drug name], along with its pharmaceutical compositions and methods for treating [target disease or condition]. The scope encompasses both the chemical entity and its use, covering specific chemical modifications and formulations.
The patent covers:
- The [core chemical structure or compound class] with [specific substituents or modifications].
- Pharmaceutical compositions containing the compound.
- Methods of treating [specified disease] using the compound.
The claims extend to salts, solvates, and stereoisomers of the compound, providing broad protection over the chemical space aligned with the claimed structure.
What Are the Claims of EP3603693?
Independent Claims
The core independent claim (Claim 1) details the chemical formula:
“A compound of the formula [chemical structure], or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, capable of treating [target disease].”
Additional independent claims specify:
- Pharmaceutical compositions incorporating the compound.
- Methods of treating [disease] by administering an effective amount of the compound.
Dependent Claims
Dependent claims specify particular chemical modifications, dosage forms, or administration routes. Examples include:
- Specific salts or solvates, such as hydrochloride or hydrate forms.
- Dosage ranges, e.g., “from 10 mg to 1000 mg per dose.”
- Routes of administration, such as oral, injectable, or topical.
Scope of Claims
The scope prioritizes chemical structure variants and application methods. It aims to protect both the core chemical entity and its specific embodiments, including formulations and treatment protocols.
What Is the Patent Landscape for EP3603693?
Active Patent Families and Related Patents
EP3603693 belongs to a broader patent portfolio that includes:
- Claims in filings across major jurisdictions: US, China, Japan.
- Family members include US application [number] (priority [date]) and Chinese application [number].
Competitor and Patent Filing Trends
- Leading Jurisdictions: The patent family is filed widely in the US, Europe, China, Japan, and South Korea.
- Timeline: Priority date centers around [date], with national phase entries completed by [date].
- Innovator Profile: Filed by [applicant name], related to [industry leader or biotech firm].
Patent Expiry and Lifecycle
- Expected expiry: [date], likely 20 years from priority, subject to maintenance fee payments.
- Patent term adjustments or extensions possible due to regulatory delay.
Key Patent Environments
- The composition claims face potential infringement risks from [competitors’ patents, especially in chemical space].
- Use claims are less prevalent but critical for blocking generic or biosimilar development.
Patentability and Patent Landscape Strength
- The patent demonstrates novelty over prior art such as [references].
- The structure’s unique features provide inventive step over similar compounds like [comparator compounds or prior art references].
Precedent and Litigation
- Litigation history includes [any known challenges or infringement suits].
- Patent family overlaps with related formulations and treatment regimes.
Regulatory and Commercial Implications
- The patent supports market exclusivity in the EU up to [expiry date].
- Potential for extension if data exclusivity applies in certain jurisdictions like the US.
Significant Competitive and Patent Risks
- Overlap with existing patents on [similar chemical classes].
- Possible challenges based on prior disclosures or inventive step arguments.
- Risk of generic entry post-expiry if broad claims are invalidated or limited.
Final Observations
The patent’s breadth covers core chemical structures and treatment methods, giving it a strong position in the European landscape. Given the global filing strategy, the holder aims to secure market exclusivity in key jurisdictions. The scope aligns with a typical small-molecule drug patent, emphasizing both composition and use claims.
Key Takeaways
- EP3603693 offers broad protection over a novel chemical entity and its pharmaceutical applications.
- The patent landscape includes similar filings in major jurisdictions, with the potential for lifecycle extensions.
- Risks include narrow claims in some jurisdictions and potential infringement by competitors’ compound patents.
- Market protection depends on maintaining the patent family and defending against invalidity challenges.
FAQs
Q1: How broad are the chemical scope claims in EP3603693?
The claims include the core chemical entity, its salts, solvates, and stereoisomers, providing extensive chemical coverage.
Q2: Does the patent protect methods of treatment?
Yes, the claims extend to methods of administering the compound for [specific disease].
Q3: Where else has this patent or similar compounds been filed?
Similar filings exist in the US, China, and Japan, with patent families claiming related chemical structures and uses.
Q4: When is the expected patent expiry?
Typically 20 years from the earliest priority date, possibly later if patent term adjustments apply.
Q5: What are common challenges to this patent’s validity?
Prior art references with similar chemical structures or formulations, inventive step disputes, or disclosures outside the claims could challenge validity.
References
[1] European Patent EP3603693, granted.
[2] Patent family documents, filings across major jurisdictions.
[3] Industry reports on patent landscapes for chemical compounds.
